Senate Hearing on Type 1 Diabetes Research and Funding

Senate Diabetes Caucus Hearing

• 💡 The Senate Appropriations Committee convened a hearing in conjunction with the Breakthrough T1D Children's Congress to discuss type 1 diabetes research.
• 🎯 Over 170 delegates traveled from across the U.S. and five other countries to share personal stories with members of Congress, highlighting the importance of their advocacy in motivating support for research.

Progress and Breakthroughs in T1D Research

• 🚀 Federal funding for diabetes research has significantly increased from $319 million in 1997 to over $2.3 billion, with notable advancements like the FDA-approved artificial pancreas and stem cell-based research for type 1 diabetes.
• 🔬 The Special Diabetes Program (SDP) at the NIH has been crucial, supporting technologies like continuous glucose monitors and leading to trials where many participants no longer require insulin after a year.
• ⚠️ Concerns were raised about potential funding freezes and cuts to NIDDK grants by the Trump administration, emphasizing that Congress, not the administration, decides funding for diabetes research.

Personal Stories and Lived Experiences

• 🌟 Young individuals, including Ruby Whitmore, Rachel White, and Katie Bone, shared their experiences managing type 1 diabetes while pursuing demanding activities like sports and academics, underscoring the daily challenges and invisible burdens.
• 🎗️ Testimonies highlighted the emotional and physical toll of T1D, the constant need for management, and the frustration of balancing daily life with the disease, while also expressing hope for a future cure.
• 👨‍👩‍👧‍👦 The immense support provided by families, particularly mothers, was recognized as critical in helping individuals manage the disease and thrive.

Future of T1D Research and Funding

• 📈 The reauthorization of the Special Diabetes Program through 2027 is a key legislative goal to ensure continued progress in treatments and cures.
• 🔬 Continued federal investment in research is deemed essential for achieving major breakthroughs, including cellular therapies and a biological cure for type 1 diabetes.
• 🗣️ Advocates stressed the importance of their voices and personal stories in driving legislative action and maintaining strong investments in diabetes research, pushing back against proposed cuts and funding freezes.

Addressing Disparities and Prevention

• 🌍 The SDP also supports prevention and treatment services for American Indians and Alaskan Natives, who have higher rates of type 2 diabetes.
• 💡 Research is ongoing to understand triggers for type 1 diabetes and develop therapies to delay or prevent its onset, with a new drug, teplizumab, showing success in delaying diagnosis for at least three years.
• 🤰 Efforts are underway to study diabetes management during pregnancy, including gestational diabetes, to improve outcomes for mothers and children.